バイオテクノロジー/医薬品サービス外注の世界市場分析:サービス別(コンサルティング、監査・評価、規制業務、製品メンテナンス、製品設計と開発、製品テスト&検証、訓練・教育)、セグメント予測、2014-2025

【英語タイトル】Biotechnology/Pharmaceutical Services Outsourcing Market Analysis, By Service (Consulting, Auditing & Assessment, Regulatory Affairs, Product Maintenance, Product Design & Development, Product Testing & Validation, Training & Education), And Segment Forecasts, 2014-2025

Grand View Researchが出版した調査資料(GVIEW707130)・商品コード:GVIEW707130
・発行会社(調査会社):Grand View Research
・発行日:2016年12月14日
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,950 ⇒換算¥559,350見積依頼/購入/質問フォーム
Multi UserUSD7,950 ⇒換算¥898,350見積依頼/購入/質問フォーム
Global/corporate LicenseUSD9,950 ⇒換算¥1,124,350見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、バイオテクノロジー/医薬品サービス外注の世界市場について調査・分析し、バイオテクノロジー/医薬品サービス外注の世界市場動向、バイオテクノロジー/医薬品サービス外注の世界市場規模、市場予測、セグメント別バイオテクノロジー/医薬品サービス外注市場分析、主要地域別市場規模、競争状況、関連企業情報などを含め、以下の構成でお届け致します。
【レポートの概要】

The global biotechnology services outsourcing market is expected to reach USD 92.9 billion by 2025, according to a new report by Grand View Research, Inc. Pharmaceutical industry has been adaptive of the function of outsourcing certain clinical and corporate functions as early as 2002. Among the services outsourced, clinical trial management and contract manufacturing were the forerunners. For instance, Johnson & Johnson was the first pharmaceutical company to outsource its applications development and maintenance (ADM).
In 2015, over USD 50.0 billion was spent on pharmaceutical R&D activities majorly on oncology, diabetes, and autoimmune therapy classes, which is expected to propel the biotechnology services outsourcing market growth over the forecast period.

Shrinking profit margins coupled with rising competition in the market space, and augmenting regulatory burden are other vital impact rendering factors. The pharmaceutical services outsourcing market is expected to register growth at a CAGR of 8.7% during the forecast period. On the other hand, pending immigration legislations in the U.S. may hinder business economics and outsourcing risks.

Pharmaceutical and biotechnology industries in Europe are significantly investing in R&D in the recent year owing to rising demand for advanced medicines. This may be attributed to increasing aging population, incidence of chronic diseases, and communicable diseases.

Further key findings from the study suggest:

Consulting services are inclusive of regulatory compliance, remediation, and quality management systems consulting, which is expected to dominate the pharmaceutical services outsourcing market in 2025.

In 2013, the U.S. FDA revised the guidelines for registration trials of drugs used in the treatment of acute bacterial skin and skin structure infections, thereby promoting growth of regulatory affairs services.

Other services such as contract manufacturing, product upgrade, and IT consulting services are projected to grow swiftly. Increasing focus on generic medicine and regional expansions in developing regions are some of the key contributing factors

Presence of cheap labor, skilled personnel and rapid growth of the pharmaceutical industry within the Asia Pacific region presents numerous opportunities for service providers, thereby representing a lucrative growth rate over the forecast period.

Service based expertise may be found in players such QuintilesIMS, Parexel Corporation, Lachman Consultant Services, Inc., Concept Heidelberg GmbH, and others. These players compete on the basis of service quality, competitive pricing, and long-term relations with healthcare industry participants.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
1.3 Country wise market calculation
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Pharmaceutical/Biotechnology Services Outsourcing Market Variables, Trends, & Scope
3.1 Market Segmentation & Scope
3.2 Market size and growth prospects
3.3 Market driver analysis
3.4 Market restraint analysis
3.5 Key Opportunities Prioritized
3.6 Industry Analysis Porter’s
3.7 Pharmaceutical/biotechnology services outsourcing PESTEL Analysis
3.8 Service pricing analysis
Chapter 4 Pharmaceutical/Biotechnology Services Outsourcing Market: Service Estimates & Trend Analysis
4.1 Pharmaceutical/biotechnology services outsourcing market: Service movement analysis
4.2 Consulting services
4.2.1 Consulting services market, 2014 – 2025 (USD Million)
4.2.2 Regulatory compliance
4.2.2.1 Regulatory compliance based consulting services market, 2014 – 2025 (USD Million)
4.2.3 Remediation
4.2.3.1 Remediation based consulting services market, 2014 – 2025 (USD Million)
4.2.4 Quality management
4.2.4.1 Quality management based consulting services market, 2014 – 2025 (USD Million)
4.2.5 Other
4.2.5.1 Other consulting services market, 2014 – 2025 (USD Million)
4.3 Auditing & assessment
4.3.1 Auditing & assessment services market, 2014 – 2025 (USD Million)
4.4 Regulatory affairs services
4.4.1 Regulatory affairs services market, 2014 – 2025 (USD Million)
4.4.2 Clinical trial applications & product registration
4.4.2.1 Clinical trial application & product registration based regulatory affairs services market, 2014 – 2025 (USD Million)
4.4.3 Regulatory writing & publishing
4.4.3.1 Regulatory writing & publishing based regulatory affairs services market, 2014 – 2025 (USD Million)
4.4.4 Legal representation
4.4.4.1 Legal representation based regulatory affairs services market, 2014 – 2025 (USD Million)
4.4.5 Other
4.4.5.1 Other regulatory affairs services market, 2014 – 2025 (USD Million)
4.5 Product maintenance services
4.5.1 Product maintenance services market, 2014 – 2025 (USD Million)
4.6 Product design & development
4.6.1 Product design & development services market, 2014 – 2025 (USD Million)
4.7 Product testing & validation
4.7.1 Product testing & validation services market, 2014 – 2025 (USD Million)
4.8 Training & education
4.8.1 Training & education services market, 2014 – 2025 (USD Million)
4.9 Other services
4.9.1 Other services market, 2014 – 2025 (USD Million)
Chapter 5 Pharmaceutical/Biotechnology Services Outsourcing Market: Regional Estimates & Trend Analysis
5.1 Pharmaceutical/biotechnology services outsourcing Market Share by Region, 2015 & 2025
5.2 North America
5.2.1 North America pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.2.2 U.S.
5.2.2.1 U.S. pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.2.3 Canada
5.2.3.1 Canada pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.3 Europe
5.3.1 Europe pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.3.2 UK
5.3.2.1 UK pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.3.3 Germany
5.3.3.1 Germany pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.4 Asia Pacific
5.4.1 Asia Pacific pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.4.2 Japan
5.4.2.1 Japan pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.4.3 China
5.4.3.1 China pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.5 Latin America
5.5.1 Latin America pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.5.2 Brazil
5.5.2.1 Brazil pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.5.3 Mexico
5.5.3.1 Mexico pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.6 MEA
5.6.1 MEA pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
5.6.2 South Africa
5.6.2.1 South Africa pharmaceutical/biotechnology services outsourcing market estimates and forecasts, 2014 – 2025
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Company Profiles
6.2.1 The Quantic Group
6.2.1.1 Company Overview
6.2.1.2 Financial performance
6.2.1.3 Geographic foothold
6.2.1.4 Product Benchmarking
6.2.2 QuintilesIMS
6.2.2.1 Company Overview
6.2.2.2 Financial Performance
6.2.2.3 Geographic foothold
6.2.2.4 Product Benchmarking
6.2.2.5 Strategic Initiatives
6.2.3 Parexel International Corporation
6.2.3.1 Company Overview
6.2.3.2 Financial Performance
6.2.3.3 Geographic foothold
6.2.3.4 Service Benchmarking
6.2.3.5 Strategic Initiatives
6.2.4 Lachman Consultant Services, Inc.
6.2.4.1 Company Overview
6.2.4.2 Financial performance
6.2.4.3 Geographic foothold
6.2.4.4 Product Benchmarking
6.2.4.5 Strategic Initiatives
6.2.5 GMP Pharmaceuticals Pty Ltd.
6.2.5.1 Company Overview
6.2.5.2 Geographic foothold
6.2.5.3 Geographic foothold
6.2.5.4 Product Benchmarking
6.2.5.5 Strategic Initiatives
6.2.6 Management Forum
6.2.6.1 Company overview
6.2.6.2 Financial performance
6.2.6.3 Geographic foothold
6.2.6.4 Product benchmarking
6.2.6.5 Strategic initiatives
6.2.7 Quality Context Ltd.
6.2.7.1 Company overview
6.2.7.2 Geographic foothold
6.2.7.3 Product benchmarking
6.2.7.4 Strategic initiatives
6.2.8 Inspired Pharma Training Ltd.
6.2.8.1 Company overview
6.2.8.2 Financial performance
6.2.8.3 Geographic foothold
6.2.8.4 Product benchmarking
6.2.9 Concept Heidelberg GmbH
6.2.9.1 Company overview
6.2.9.2 Financial performance
6.2.9.3 Geographic foothold
6.2.9.4 Product benchmarking
6.2.9.5 Strategic initiatives
6.2.10 Reading Scientific Services Ltd. (RSSL)
6.2.10.1 Company overview
6.2.10.2 Financial performance
6.2.10.3 Geographic foothold
6.2.10.4 Product benchmarking
6.2.10.5 Strategic initiatives

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Primary interviews in North America
FIG. 8 Primary interviews in Europe
FIG. 9 Primary interviews in Asia Pacific
FIG. 10 Primary interviews in Latin America
FIG. 11 Primary interviews In MEA
FIG. 12 Market summary, 2015 (USD Million)
FIG. 13 Market trends & outlook
FIG. 14 Pharmaceutical/biotechnology services outsourcing market: Market segmentation
FIG. 15 Pharmaceutical/biotechnology services outsourcing market revenue, (USD Million), 2014 - 2025
FIG. 16 Market driver relevance analysis (Current & future impact)
FIG. 17 Increasing number of the FDA approved NME, 2008-2014
FIG. 18 Number of mergers and acquisition vs value (USD Billion), 2010-2014
FIG. 19 Average cost per new drug development, 2000 - 2011 (USD Million)
FIG. 20 Failure rates in phase transitions during biopharmaceutical development
FIG. 21 Market restraint relevance analysis (Current & future impact)
FIG. 22 Key Opportunities Prioritized
FIG. 23 Pharmaceutical/biotechnology services outsourcing: Porter’s analysis
FIG. 24 Pharmaceutical/biotechnology services outsourcing PESTEL analysis
FIG. 25 Reasons for outsourcing, 2015
FIG. 26 Heat map for pricing models opted by competitors
FIG. 27 Pharmaceutical/biotechnology services outsourcing market service outlook key takeaways
FIG. 28 Pharmaceutical/biotechnology services outsourcing market: Service movement analysis
FIG. 29 Consulting services market, 2014 - 2025 (USD Million)
FIG. 30 Regulatory compliance based consulting services market, 2014 - 2025 (USD Million)
FIG. 31 Remediation based consulting services market, 2014 - 2025 (USD Million)
FIG. 32 Quality management based consulting services market, 2014 - 2025 (USD Million)
FIG. 33 Other consulting services market, 2014 - 2025 (USD Million)
FIG. 34 Auditing & assessment services market, 2014 - 2025 (USD Million)
FIG. 35 Regulatory affairs services market, 2014 - 2025 (USD Million)
FIG. 36 Clinical trial application & product registration based regulatory affairs services market, 2014 - 2025 (USD Million)
FIG. 37 Regulatory writing & publishing based regulatory affairs services market, 2014 - 2025 (USD Million)
FIG. 38 Legal representation based regulatory affairs services market, 2014 - 2025 (USD Million)
FIG. 39 Other regulatory affairs services market, 2014 - 2025 (USD Million)
FIG. 40 Product maintenance services market, 2014 - 2025 (USD Million)
FIG. 41 Product design & development services market, 2014 - 2025 (USD Million)
FIG. 42 Product testing & validation services market, 2014 - 2025 (USD Million)
FIG. 43 Training & education services market, 2014 - 2025 (USD Million)
FIG. 44 Other services market, 2014 - 2025 (USD Million)
FIG. 45 Regional market place: Key takeaways
FIG. 46 Regional outlook, 2015 & 2025
FIG. 47 North America pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 48 U.S. pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 49 Canada pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 50 Europe pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 51 UK pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 52 Germany pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 53 Asia Pacific pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 54 Japan pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 55 China pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 56 Latin America pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 57 Brazil pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 58 Mexico pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 59 MEA pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 60 South Africa pharmaceutical/biotechnology services outsourcing market, 2014 - 2025 (USD Million)
FIG. 61 Strategy framework
FIG. 62 Global presence of The Quantic Group
FIG. 63 SWOT Analysis
FIG. 64 Global presence of QuintilesIMS
FIG. 65 SWOT Analysis
FIG. 66 Global presence of Parexel International Corporation
FIG. 67 SWOT Analysis
FIG. 68 Global presence of Lachman Consultant Services, Inc.
FIG. 69 SWOT Analysis
FIG. 70 Global presence of GMP Pharmaceuticals Pty Ltd.
FIG. 71 SWOT Analysis
FIG. 72 Global presence of Management Forum
FIG. 73 SWOT analysis
FIG. 74 Global presence of Quality Context Ltd.
FIG. 75 SWOT analysis
FIG. 76 Global presence of Inspired Pharma
FIG. 77 SWOT analysis
FIG. 78 Global presence of Concept Heidelberg GmbH
FIG. 79 SWOT analysis
FIG. 80 Global presence of RSSL
FIG. 81 SWOT analysis

List of Tables

TABLE 1 Country wise market share percentage
TABLE 2 Pricing strategy for outsourcing business models
TABLE 3 Outsourcing services average prices, 2015
TABLE 4 Partnerships between CRO’s and pharmaceutical firms
TABLE 5 Provisional rate for consulting roles
TABLE 6 North America pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
TABLE 7 North America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 8 North America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 9 North America pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 10 U.S. pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 11 U.S. pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 12 U.S. pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 13 Canada pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 14 Canada pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 15 Canada pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 16 Europe pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
TABLE 17 Europe pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 18 Europe pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 19 Europe pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 20 UK pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 21 UK pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 22 UK pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 23 Germany pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 24 Germany pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 25 Germany pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 26 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
TABLE 27 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 28 Asia Pacific pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 29 Asia Pacific pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 30 Japan pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 31 Japan pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 32 Japan pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 33 China pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 34 China pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 35 China pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 36 Latin America pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
TABLE 37 Latin America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 38 Latin America pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 39 Latin America pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 40 Brazil pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 41 Brazil pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 42 Brazil pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 43 Mexico pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 44 Mexico pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 45 Mexico pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 46 MEA pharmaceutical/biotechnology services outsourcing market, by region, 2014 - 2025 (USD Million)
TABLE 47 MEA pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 48 MEA pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 49 MEA pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 50 South Africa pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 51 South Africa pharmaceutical/biotechnology services outsourcing market, by service, 2014 - 2025 (USD Million)
TABLE 52 South Africa pharma/biotechnology regulatory affairs services market, by service, 2014 - 2025 (USD Million)
TABLE 53 Regional office locations



★調査レポート[バイオテクノロジー/医薬品サービス外注の世界市場分析:サービス別(コンサルティング、監査・評価、規制業務、製品メンテナンス、製品設計と開発、製品テスト&検証、訓練・教育)、セグメント予測、2014-2025] (コード:GVIEW707130)販売に関する免責事項を必ずご確認ください。
★調査レポート[バイオテクノロジー/医薬品サービス外注の世界市場分析:サービス別(コンサルティング、監査・評価、規制業務、製品メンテナンス、製品設計と開発、製品テスト&検証、訓練・教育)、セグメント予測、2014-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆